Prevalence and Clinical Features of Vesicoureteral Reflux in Children With Recurrent Urinary Tract Infections: A Cross‐Sectional Study Authors: Niloufar Peirovi, Neda Pak, Mastaneh Moghtaderi, Arash Abbasi, Behnaz Bazargani, Fahimeh Askarian, Daryoosh Fahimi, Mahboube Bahroudi Published: 2026 ABSTRACT ABSTRACTBackground and AimsVesicoureteral reflux (VUR) is one of the most common congenital anomalies in children with urinary tract infections (UTIs), potentially leading to serious complications, including renal scarring and permanent kidney damage. This study aimed to assess the prevalence, laterality, and severity of VUR and its associations with demographic, clinical, and functional factors in children with recurrent UTIs.MethodsThis cross‐sectional study examined 109 children aged 2 months to 5 years with recurrent UTIs who were referred to a tertiary center of nephrology clinic. Data collected included age at diagnosis, renal scarring, constipation, voiding dysfunction, gender, VUR grade, and laterality.ResultsOf the 109 children studied, 51.38% had VUR (unilateral or bilateral). The majority of patients were female (78.9%). Unilateral reflux (29.35%) was more frequent than bilateral reflux (22.01%). Among those with VUR, 58.9% had mild to moderate reflux (grades 1–3), while 41.07% had severe reflux (grades 4–5). Renal parenchymal scarring was present in 30.2% of cases, more commonly affecting the right kidney (18.3%) than the left (4.6%). Voiding dysfunction was highly prevalent (66.1%) and was significantly associated with VUR. Most patients (85.3%) received antibiotic prophylaxis, although its association with renal scarring was not statistically significant.ConclusionThis study identified a higher prevalence of VUR among children with recurrent UTIs than previously reported, with unilateral and mild‐to‐moderate reflux being predominant. The findings highlight the interplay between female gender, voiding dysfunction, and VUR in recurrent pediatric UTIs. Early detection and targeted management, including addressing bladder–bowel dysfunction and judicious use of antibiotic prophylaxis, are essential to prevent recurrent infections and reduce the risk of renal damage.Keywords: children, recurrent urinary tract infections, vesicoureteral reflux Introduction Urinary tract infection (UTI) is one of the most common bacterial infections in children, and represents a major cause of morbidity in pediatric practice. The prevalence of UTIs in childhood is approximately 8%, varying significantly with age, ethnicity, gender, and circumcision status [1, 2, 3]. Although many episodes are isolated and self‐limiting, recurrent infections often point toward an underlying anatomical or functional abnormality of the urinary tract. Recurrent UTI is defined as two or more culture‐confirmed infections within 6 months or three or more within 1 year [4]. The significance of UTIs in pediatric healthcare is heightened by their association with vesicoureteral reflux (VUR). VUR, characterized by the retrograde flow of urine from the bladder into the ureters and renal pelvis, is detected in approximately 30%–50% of children with recurrent UTIs, with the highest prevalence seen in infants and younger children [5, 6]. The relationship between UTIs and VUR is particularly concerning. Reflux‐associated UTIs often progress to pyelonephritis and reflux nephropathy, as VUR creates a direct pathway for contaminated urine between the bladder and kidneys [7, 8]. Reflex nephropathy refers to permanent renal scarring that may lead to hypertension, proteinuria, and chronic kidney injury later in life [9, 10]. Early diagnosis and management are therefore crucial to preserving renal function and minimizing long‐term sequelae [10, 11]. However, it is important to acknowledge that in clinical and imaging practice, particularly within nuclear medicine centers, a clear distinction between renal dysplasia and acquired scarring is not always made [12]. Subtle congenital dysplasia, especially in infants, is often misclassified as post‐infectious scarring on dimercaptosuccinic acid (DMSA) scans, confounding the true prevalence of acquired renal scarring in children with VUR and UTI [13, 14]. This overlap poses a challenge for both accurate epidemiological reporting and long‐term patient monitoring. In addition, monitoring of children with VUR or recurrent UTIs extends beyond imaging. Comprehensive follow‐up should include periodic clinical evaluation, blood pressure monitoring, and biochemical assessment [15]. In addition to annual renal ultrasound, measurement of serum creatinine and urine protein‐to‐creatinine ratio is critical to assess ongoing renal function and identify early signs of dysplasia or progressive scarring, especially in those with abnormal DMSA findings or persistent reflux [15, 16, 17]. These parameters provide essential insight into both the stability and long‐term prognosis of renal function in patients affected by this condition. Given these diagnostic and management complexities, updated region‐specific data on the prevalence and clinical features of VUR are needed. Evidence suggests that ethnic and regional factors influence both the occurrence and clinical course of VUR [18, 19, 20]. In Middle Eastern and South Asian populations, including those in Iran, genetic and healthcare system factors may shape VUR epidemiology differently from Western cohorts. Despite several Iranian studies evaluating VUR after a first UTI, limited research has focused specifically on recurrent infections, the subgroup at highest risk for renal damage. This cross‐sectional study aims to determine the prevalence of VUR among Iranian children with recurrent UTIs and to describe their clinical and demographic characteristics, including infection patterns, imaging findings, and associated risk factors. By addressing the lack of region‐specific data, this study seeks to enhance understanding of VUR‐related renal outcomes in Iranian children and inform more targeted monitoring and management strategies. Materials and Methods This cross‐sectional study was conducted to determine the prevalence and characteristics of vesicoureteral reflux (VUR) in children with recurrent urinary tract infections (UTIs). The study design and reporting followed the CONSORT 2010 Statement for transparent reporting of clinical research [21]. Study Design and Population A total of 109 children were selected from patients attending the nephrology clinic of a tertiary referral hospital affiliated with Tehran University of Medical Sciences during October 2011 to October 2019. Eligible participants included children aged ≤ 5 years with recurrent UTI, defined as two or more culture‐confirmed UTIs within 6 months or three or more episodes within 1 year. Exclusion criteria included incomplete records, urological malformations other than VUR, prior genitourinary surgery, or secondary causes of reflux (e.g., posterior urethral valves, neurogenic bladder). The study collected comprehensive patient data from medical records, including age at diagnosis (time of diagnosis by a specialist physician), presence of kidney parenchymal scarring, constipation condition, voiding dysfunction, gender, reflux grade, and whether the reflux was unilateral or bilateral. Given that the study was conducted at a tertiary referral center, the study population likely represented children with more complex or severe disease profiles than those typically seen in general community settings. This selection bias was inherent to the study design and is acknowledged as a limitation affecting external generalizability. Diagnostic Methods All patients underwent diagnostic imaging for VUR using voiding cystourethrography (VCUG), which was performed according to a standardized institutional protocol by trained radiologists. The grading of reflux was based on the International Reflux Study Committee classification (Grades I–V). DMSA renal scintigraphy was used to identify renal parenchymal scarring or congenital dysplasia, interpreted by board‐certified nuclear medicine specialists following hospital‐standard imaging protocols. Hydronephrosis was evaluated via renal ultrasonography at the time of diagnosis and during follow‐up. Sample Size and Statistical Methods The required sample size was determined using the standard formula for cross‐sectional studies estimating population proportions, with parameters set at expected proportion (P) = 0.35, confidence level (Z) = 1.95, and precision (d) = 0.10. This calculation ensured adequate statistical power (≥ 80%) for the study's primary outcome. All analyses were conducted using IBM SPSS Statistics for Windows, Version 26.0 (IBM Corp., Armonk, NY, USA). All statistical analyses and reporting were performed in accordance with the Guidelines for Reporting of Statistics for Clinical Research in Urology [22] and the Statistical Analyses and Methods in the Published Literature (SAMPL) guidelines [23]. Continuous variables are presented as mean ± standard deviation (SD), and categorical variables as frequency (n) and percentage (%). The primary, pre‐specified analyses included: (1) comparison of age and sex distribution across VUR categories (no VUR, unilateral, bilateral); (2) association of clinical features (renal scarring, voiding dysfunction, constipation, hydronephrosis) with the presence or absence of VUR; (3) evaluation of longitudinal changes in hydronephrosis among diagnostic groups. Exploratory subgroup analyses were performed to further assess associations between VUR laterality (right vs. left) and renal scarring patterns. Normality was assessed using the Shapiro–Wilk test. For normally distributed continuous data, one‐way ANOVA was applied; for non‐normally distributed data, the Kruskal–Wallis test was used. Categorical variables were analyzed using the Chi‐square (χ²) test. Repeated Measures ANOVA was performed to assess longitudinal changes in hydronephrosis grade between the initial and final ultrasonographic evaluations. All statistical tests were two‐sided, and a p‐value < 0.05 was considered statistically significant. Ethical Considerations The study protocol was approved by the Ethics Committee of Tehran University of Medical Sciences (Approval No. IR.TUMS.CHMC. REC.1397.108). All procedures adhered to the principles of the Declaration of Helsinki. Written informed consent was obtained from parents or legal guardians prior to participation. Results A total of 109 children with recurrent UTIs were included in the study, with ages at diagnosis ranging from birth to 60 months (mean ± SD = 28.87 ± 20.95 months). The study population comprised 86 girls (78.9%) and 23 boys (21.1%). Distribution of VUR by Age and Sex The distribution of VUR among participants included four categories: no VUR, left unilateral, right unilateral, and bilateral VUR. As shown in Figure 1A, 53 children (48.6%) had no VUR, 32 (29.4%) had unilateral VUR, and 24 (22.0%) had bilateral VUR. Among unilateral cases, left‐sided VUR was predominant (24 of 32; 75%), indicating a lateral tendency toward left kidney involvement. Notably, Kruskal‐Wallis results showed significant differences in mean age at diagnosis across VUR categories (p < 0.001; Table 1). Children with bilateral VUR were diagnosed at a younger age, suggesting that more severe or symptomatic cases may present earlier in life. Although females constituted the majority of the cohort (78.9%), VUR severity patterns differed by sex. While most girls were free of VUR, bilateral VUR occurred more frequently among boys (56.5%) than girls (12.8%) (p < 0.001; Table 1). This finding indicates that male sex may be associated with more severe forms of VUR during early childhood. Distribution of VUR pattern (A) and grade (B) among participants. VUR, Vesicourethral reflux. Table 1Distribution of VUR patterns by sex and age at diagnosis.Reflux patternTotal n (%)Age (months) mean ± SDFemale n (%)Male n (%) p value (sex, age)No VUR53 (48.6)32.1 ± 21.448 (55.8)5 (21.7)< 0.001Left unilateral VUR24 (22.0)27.3 ± 19.220 (23.18)4 (17.36)Right unilateral VUR8 (7.3)25.9 ± 20.17 (8.11)1 (4.34)Bilateral VUR24 (22.0)20.6 ± 18.511 (12.8)13 (56.5)Abbreviations: n, number; SD, standard deviation; VUR, vesicoureteral reflux. Distribution of VUR patterns by sex and age at diagnosis. Abbreviations: n, number; SD, standard deviation; VUR, vesicoureteral reflux. VUR Grade Distribution Among children with VUR, grade distribution demonstrated that intermediate to severe grades were more frequent than mild cases (Figure 1B). Grade 2 VUR was most common (16.5%), followed by grades 4 (11.0%), 5 (10.1%), and 3 (8.3%), while grade 1 was least common (5.5%). Chi‐square results showed statistical differences among grade distributions (p < 0.001). This pattern reflects a higher prevalence of clinically significant VUR among affected children. Clinical Features Distribution Table 2 summarizes the clinical characteristics of participants. Renal parenchymal scarring was identified in 33 children (30.3%). Of these, 8 (7.3%) had bilateral involvement, while 25 (22.9%) had unilateral scarring. Right‐sided scarring predominated (20 out of 25 unilateral cases, 80%), indicating a potential predisposition for right kidney damage (Chi‐square test, p < 0.001). The observed association between VUR and renal scarring highlights the importance of early detection to prevent irreversible renal injury. In addition, constipation was reported in 66 children (60.6%). Although VUR was somewhat more frequent among constipated patients (43.9%), this association did not reach statistical significance (Chi‐square test, p = 0.057). Further, dysfunction was documented in 72 children (66.1%). Among them, 40.3% had VUR, a significantly higher rate compared to those without voiding dysfunction (p < 0.001). This finding underscores the close clinical relationship between voiding abnormalities and VUR in pediatric UTIs. Table 2Distribution of clinical features and interventions.Clinical variableTotal n (%)With VUR n (%)Without VUR n (%) p valueConstipation66 (60.6)29 (43.9)37 (56.1)0.06Voiding dysfunction72 (66.1)29 (40.3)43 (59.7)< 0.001Renal parenchymal scarring33 (30.3)25 (75.8)8 (24.2)< 0.001Hydronephrosis59 (54.1)37 (62.7)22 (37.3)< 0.001Surgical intervention22 (20.2)22 (100)—< 0.001Antibiotic prophylaxis93 (85.3)50 (53.8)43 (46.2)0.44Abbreviations: n, number; VUR, vesicoureteral reflux. Distribution of clinical features and interventions. Abbreviations: n, number; VUR, vesicoureteral reflux. Hydronephrosis was observed in 59 children (54.1%). VUR was present in 62.7% of these cases (Chi‐square test, p < 0.001), indicating a strong association between hydronephrosis and VUR. Unilateral hydronephrosis was predominant (51%), with a marked left‐sided preference (41%), suggesting that left‐sided VUR may contribute disproportionately to hydronephrosis development. Serial ultrasonography revealed a reduction in pelvic diameter across all groups (no VUR, right‐sided, and left‐sided VUR), although this trend did not reach statistical significance (Repeated measure ANOVA, p = 0.08). This finding suggests potential improvement over time but without conclusive evidence of a treatment‐related effect. Interventions As shown in Table 2, among 56 children with reflux, 22 (20.2%) underwent surgical correction. Bilateral VUR accounted for most surgical cases (59.1%), with statistically significant difference among VUR groups (Chi‐square test, p < 0.001). This suggests that VUR severity and laterality are key determinants of the need for surgical management. Prophylactic antibiotics were prescribed to 93 children (85.3%). Although over half (53.8%) of these children had VUR, the relationship was not statistically significant (Chi‐square test, p = 0.44), suggesting that antibiotic use alone did not correlate with reflux presence in this cohort. Discussion This study evaluated 109 children aged 2 months to 5 years with recurrent urinary tract infections (UTIs), examining parameters including vesicoureteral reflux (VUR) grade and laterality, renal scarring, voiding dysfunction, and management strategies. The mean age at diagnosis was 28.87 ± 20.95 months, with bilateral VUR presenting earlier than unilateral VUR, suggesting that more severe disease tends to manifest at a younger age. Consistent with existing literature [24], we observed a markedly higher prevalence of UTIs in girls (78.9%) compared to boys (21.1%). Similarly, a study in Saudi Arabia over 3 years showed that the prevalence of UTA with VUR was 89% in girls and 11% in boys [25]. This well‐established gender disparity is thought to be due to anatomical differences in urethral length, periurethral flora, and hygiene factors [26]. Our findings also suggest that male children may be more likely to have bilateral or more severe VUR, which has implications for risk stratification in clinical practice. We found a VUR prevalence of about 51.4%, higher than many reports (30%–50%) [1, 5, 25, 27, 28, 29]. The elevated rate of VUR in our cohort may be attributed to the nature of our center as a referral facility, which likely results in a higher concentration of more severe or complicated cases. However, such a high prevalence observed in our study likely reflects multiple interacting factors rather than referral bias alone. Other potential contributors include differences in diagnostic strategies (e.g., routine vs. selective voiding cystourethrogram [VCUG] protocols), variations in imaging sensitivity, and demographic characteristics such as a younger mean age and female predominance in our population. Both younger age at diagnosis and female sex are well‐documented risk factors for higher VUR detection rates following UTI episodes [24, 26]. Furthermore, our inclusion of children with recurrent UTIs rather than first‐time infections may have increased the likelihood of detecting reflux, as repeated infections are often associated with underlying anatomical or functional abnormalities [20]. In terms of VUR laterality, unilateral reflux was more common than bilateral, with left‐sided predominance in unilateral cases. Findings of a previous study were in contrast to this, showing a higher prevalence of bilateral VUR [25]. This variation may reflect regional variations in patient populations or differences in diagnostic practices. In addition, our findings showed that most children had mild to moderate VUR (grades I–III), though a sizable fraction had severe (grades IV–V) reflux. Our cohort demonstrated a higher prevalence of this category compared to earlier studies [25, 29]. Renal parenchymal scarring was present in 30.2% of patients, lower than some studies (~41%) [25], reinforcing that prompt detection and management of UTIs and VUR may help to limit permanent renal damage. The very small proportion of children with scarring in the absence of VUR in our cohort underscores the strong etiologic role of VUR in renal injury. Voiding dysfunction was common (66.1%) and significantly associated with VUR. This aligns with established risk factors, such as bladder–bowel dysfunction (BBD), which is repeatedly shown to increase risk of recurrent UTIs and worsen VUR outcomes [30, 31]. Therefore, assessing and managing BBD is crucial in pediatric UTI/VUR management. Hydronephrosis was detected in 54.1% of participants, with right‐sided cases being more prevalent (18.3%) than left‐sided (4.6%). Although serial imaging demonstrated a non‐significant trend toward reduced hydronephrosis across all groups, these findings emphasize the role of renal ultrasound as a non‐invasive and essential tool for monitoring disease progression [32, 33, 34]. Regular imaging follow‐up remains a cornerstone of pediatric VUR management. Surgical intervention continues to represent a critical therapeutic option, particularly for severe or refractory cases. In our study, 39.2% of children with VUR underwent surgical procedures, with bilateral cases accounting for the majority (59.1%). Surgical correction has demonstrated up to 95% success rates in reflux resolution and approximately 57% reduction in recurrent UTIs [32]. However, the decision to operate must be individualized, integrating reflux grade, infection recurrence, renal function, and bladder dynamics [35]. Our findings regarding antibiotic prophylaxis further contribute to the ongoing debate on its efficacy in preventing recurrent UTIs and renal scarring. Although 85.3% of our patients received antibiotic prophylaxis, no statistically significant association was found between prophylaxis and the presence of VUR or renal scarring. This aligns with the mixed results reported in previous randomized controlled trials (RCTs). For example, the RIVUR trial by Hoberman et al. demonstrated a reduction in recurrent febrile UTIs with prophylactic trimethoprim‐sulfamethoxazole but no significant difference in new renal scarring between the treatment and placebo groups [36]. Similarly, Craig et al. reported a modest 6% absolute reduction in UTI recurrence with prophylaxis but no effect modification by reflux grade or sex [37]. Conversely, some other studies found no significant reduction in either recurrence or scarring [38, 39, 40]. A systematic review and network meta‐analysis found no significant difference in UTI frequency after correction, whether children had endoscopic vs reimplantation surgery in high‐grade VUR, which indirectly bears on the role of medical vs surgical prevention strategies [41]. Other large trials suggest benefit in reducing recurrent UTIs in high‐risk subgroups, but less evidence for prevention of new renal scarring [27]. Taken together, these findings suggest that antibiotic prophylaxis should not be applied universally but rather tailored based on individual risk factors such as reflux grade, sex, history of febrile UTI, and voiding dysfunction. Current evidence supports a selective, risk‐based approach: prophylaxis may benefit specific high‐risk subgroups, but its broad use may contribute to antimicrobial resistance and unnecessary drug exposure [42]. Clinicians should therefore weigh potential benefits against risks, monitor adherence and adverse events, and combine prophylaxis with behavioral interventions addressing bladder and bowel dysfunction. Our results, consistent with prior RCTs, underscore the need for future longitudinal studies incorporating standardized risk stratification to refine evidence‐based recommendations for VUR management. Our findings support a tiered, individualized approach to the management of pediatric VUR. Comprehensive risk assessment should incorporate key factors such as patient age, sex, reflux severity, and bladder–bowel function to guide clinical decision‐making. Early identification and treatment of bladder–bowel dysfunction may significantly reduce the recurrence of urinary tract infections and, in some cases, promote spontaneous resolution of reflux. Antibiotic prophylaxis should be used selectively, reserved for children at the highest risk of infection recurrence or renal damage, and its effectiveness should be periodically re‐evaluated to avoid unnecessary antimicrobial exposure. Surgical intervention remains an important option for children with persistent or high‐grade VUR, particularly when conservative measures fail, and should be guided by longitudinal imaging and functional assessments. By integrating clinical, functional, and imaging parameters, pediatric nephrologists and urologists can optimize management strategies to prevent long‐term renal sequelae while minimizing overtreatment and antibiotic resistance. Conclusion Our study underscores the strong association between vesicoureteral reflux (VUR) and recurrent urinary tract infections (UTIs) in young children, with a notably high prevalence of VUR observed in our cohort. Female predominance was evident, reinforcing the well‐established gender disparity in pediatric UTIs and highlighting the need for heightened vigilance in girls presenting with recurrent infections. Additionally, the significant association between voiding dysfunction and VUR emphasizes the importance of early identification and management of bladder–bowel dysfunction as a modifiable risk factor that may reduce both infection recurrence and renal complications. While antibiotic prophylaxis remains a key preventive measure, our findings and prior evidence suggest that its role should be tailored based on individual risk profiles rather than applied universally. Future research should prioritize longitudinal studies to evaluate how sex, voiding dysfunction, and reflux severity interact to influence renal outcomes, thereby guiding more personalized and effective management strategies for pediatric VUR. Author Contributions Niloufar Peirovi: conceptualization, writing – review and editing, formal analysis, data curation. Neda Pak: conceptualization, supervision, writing – review and editing, methodology. Mastaneh Moghtaderi: conceptualization, writing – original draft, writing – review and editing, supervision, methodology, validation. Arash Abbasi: conceptualization, writing – review and editing, supervision. Behnaz Bazargani: conceptualization, writing – review and editing, supervision. Fahimeh Askarian: conceptualization, writing – review and editing, supervision. Daryoosh Fahimi: conceptualization, writing – review and editing, supervision. Mahboube Bahroudi: conceptualization, writing – original draft, methodology, supervision, writing – review and editing; software. Funding The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement The lead author Mastaneh Moghtaderi affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.